81 – 90 of 117
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Molecular profiling reveals low- and high-grade forms of primary melanoma
- Contribution to journal › Article
- 2011
-
Mark
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
- Contribution to journal › Article
-
Mark
Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene.
- Contribution to journal › Article
-
Mark
Genotyping techniques to address diversity in tumors.
- Contribution to journal › Article
- 2010
-
Mark
Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
- Contribution to journal › Article
-
Mark
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
- Contribution to journal › Article
-
Mark
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
- Contribution to journal › Article
-
Mark
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
- Contribution to journal › Article
-
Mark
Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
- Contribution to journal › Article
-
Mark
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome.
- Contribution to journal › Article
